Tarsus Pharmaceuticals
TARS
TARS
148 hedge funds and large institutions have $1.09B invested in Tarsus Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 67 increasing their positions, 41 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
148
Holders Change
-9
Holders Change %
-5.73%
% of All Funds
2.15%
Holding in Top 10
4
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-42.86%
% of All Funds
0.06%
New
26
Increased
67
Reduced
41
Closed
34
Calls
$2.26M
Puts
$22M
Net Calls
-$19.7M
Net Calls Change
-$22.9M
Top Buyers
| 1 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
$28.9M |
| 2 |
BlackRock
New York
|
$88.8M |
| 3 |
ECM
ExodusPoint Capital Management
New York
|
$18.2M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
$12.6M |
| 5 |
Millennium Management
New York
|
$9.47M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MLICM
176
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$60.2K | -1,657 | Closed |
|
|
EC
177
EntryPoint Capital
New York
| – | -$47.3K | -1,302 | Closed |
|
|
SIC
178
Salem Investment Counselors
Winston Salem,
North Carolina
| – | -$10.9K | -300 | Closed |
|
179
US Bancorp
Minneapolis,
Minnesota
| – | -$2.87K | -79 | Closed |
|
|
SPIA
180
Steward Partners Investment Advisory
New York
| – | -$2.15K | -59 | Closed |
|
|
AWM
181
Avior Wealth Management
Omaha,
Nebraska
| – | -$181 | -5 | Closed |
|